Department

Medicine

Position

Professor

Articles

• Expert Review Pharmacoeconomics Outcomes Research
  Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States, p. 1-9 2022
• J American Heart Association
  US Antiarrhythmic drug treatment for patients with atrial fibrillation: an insurance claims-based approach.
  10, p. e016792 2021
• Sr Care Pharm
  Practical Insights into Anticoagulation for an Aging Population
  35, p. 150 2020
• Advances in Therapy
  Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: an analysis using Administrative Claims Data
  35 (11), p. 1-122069-2080 2018
• Journal of the American College of Cardiology:Clinical Electrophysiology
  Hospitalization and costs in primary prevention ICD recipients: who determines the outcomes?
  4 (2), p. 254-256 2018
• Advances in Therapy
  Impact of warfarin on atrial fibrillation outcomes related to economic consumption patterns:  hospitalization, cost, and mortality may be predictable and modifiable at the population level
  33 (9), p. 1579-1599 2016
• Journal of Innovations in Cardiac Rhythm Management
  Patterns of dofetilide use for the treatment of atrial fibrillation
  7, p. 2425-2428 2016
• Journal of Managed Care & Specialty Pharmacy
  A call for appropriate evidence and outcomes-based use and measurement of anticoagulation for atrial fibrillation: moving the population towards improved health via multiple stakeholders
  21 (11), p. 1034-1038 2015
• Heart Rhythm Case Reports
  A case series of anomalous high pacing lead impedances in normally functioning leads
  1 (6), p. 449-452 2015
• Heart Rhythm
  Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions
  12 (8), p. 1728-1736 2015
• Journal of the American College of Cardiology
  Shared risk factors for anticoagulation in nonvalvular atrial fibrillation:  a dilemma in clinical decision making
  63 (20), p. 2148-2150 2014
• Journal of Managed Care Pharmacy
  Health care burden of dyspepsia among nonvalvular atrial fibrillation patients
  20 (4), p. 391-399 2014
• Advances in Therapy
  Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter
  31 (3), p. 318-332 2014
• International Journal of Clinical Cardiology
  Cardiac troponin assessment following atrial fibrillation ablation: implications for chest pain evaluation
  1 (2) 2014
• Journal of Interventional Cardiac Electrophysiology
  The relationship between defibrillation threshold and total mortality
  38 (3), p. 203-208 2013
• Journal of Interventional Cardiac Electrophysiology
  Prospective evaluation of cinefluoroscopy and chest radiography for Riata lead defects: implications for future lead screening
  38 (2), p. 131-135 2013
• Journal of Interventional Cardiac Electrophysiology
  Effectiveness of VF induction with DC Fibber versus conventional induction methods in patients on chronic amiodarone therapy
  38 (2), p. 137-141 2013
• Heart Rhythm
  Device advisory letters:  readability and comprehension, patient-centered outcomes not to be "misunderstood"
  10 (4), p. 508-509 2013
• Journal of the American College of Cardiology
  Treatment targets in atrial fibrillation:  "is feeling better good enough?"
  61, p. 461-462 2013
• Journal of Cardiovascular Electrophysiology
  Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator lead
  23 (11), p. 1207-1212 2012
• Journal of Cardiovascular Electrophysiology
  Catheter ablation of atrial fibrillation in Octogenarians:  the Right "medicine?"
  23 (7), p. 694-696 2012
• Expert Review of Clinical Pharmacology
  Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation
  5 (2), p. 163-171 2012
• Journal of Innovations in Cardiac Rhythm Management
  Concepts in disease progression of atrial fibrillation and implications for medical management
  3, p. 697-712 2012
• Journal of Cardiovascular Electrophysiology
  Long-term insertable loop monitors:  how much should we watch to get an answer (diagnosis)?
  23 (1), p. 72-73 2012
• Clinical Therapeutics
  One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis
  33 (11), p. 1668-1681 2011
• Circulation: Cardiovascular Quality and Outcomes
  Estimation of total incremental health care costs in patients with atrial fibrillation in the United States
  4 (3), p. 313-320 2011
• Heart Rhythm
  A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy
  8 (5), p. 685-691 2011
• Journal of Cardiovascular Electrophysiology
  Predicting the risk of heart failure events and subsequent mortality:  what doth the seer know?
  21 (11), p. 1224-1225 2010
• Advances in Therapy
  Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States
  27 (9), p. 600-612 2010
• Journal of Interventional Cardiac Electrophysiology
  The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation:  the Vitatron Selection AFm Registry Study
  28 (3), p. 227-234 2010
• Pacing and Clinical Electrophysiology
  Predictors of early mortality in patients age 80 and older receiving implantable defibrillators
  33 (8), p. 981-987 2010
• Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  Patterns and predictors of discontinuation of rhythm control drug therapy in patients with newly diagnosed atrial fibrillation
  29 (12), p. 1417-1426 2009
• Current Medical Research and Opinion
  Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
  25 (12), p. 3037-3047 2009
• Advances in Therapy
  Cost of atrial fibrillation in United States managed care organizations
  26 (9), p. 847 2009
• Journal of Cardiovascular Electrophysiology
  Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy
  20 (8), p. 894-900 2009
• Advances in Therapy
  National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US
  26 (8), p. 784-794 2009
• Journal of Cardiovascular Electrophysiology
  A novel method for sinus node modification and phrenic nerve protection in resistant cases
  20 (6), p. 689-691 2009
• Current Medical Research and Opinion
  Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation
  25 (5), p. 1215-1220 2009
• Annals of Pharmacotherapy
  Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation
  43 (5), p. 840-848 2009
• Journal of Electrocardiology
  Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual chamber pacemakers
  42 (2), p. 128-135 2009
• Journal of cardiovascular nursing
  A written policy increases compliance with guidelines for therapeutic anticoagulation prior to elective direct current cardioversion of atrial fibrillation
  22 (5), p. 417-421 2007
• Journal of Cardiovascular Electrophysiology
  A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy
  18 (5), p. 490-496 2007
• Pacing and Clinical Electrophysiology
  Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation:  an opportunity to improve rates of warfarin utilization
  30 (4), p. 580-583 2007
• Occupational and Environmental Medicine
  Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air polllutants in the St. Louis, Missouri metropolitan area
  63 (9), p. 591-596 2006
• Heart Rhythm
  Left bundle branch block during orthodromic reciprocating tachycardia:  where is the accessory pathway?
  3 (5), p. 610-611 2006
• Journal of Heart and Lung Transplantation
  Cardiac resynchronization therapy:  a potential option for congenitally corrected transposition of the great vessels
  24 (12), p. 2293-2296 2005
• Pacing and Clinical Electrophysiology
  Polymorphic ventricular tachycardia with a normal QT interval following azithromycin
  28 (11), p. 1221-1222 2005
• Annals of Internal Medicine
  Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery:  a meta-analysis
  143 (5), p. 327-336 2005
• Archives of Internal Medicine
  Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
  165 (10), p. 1185-1191 2005
• The Lancet
  Cardiac pacing:  the state of the art
  364, p. 1701-1719 2004
• Cardiac Electrophysiology Review
  Low molecular weight heparin in atrial fibrillation management:  facts, fiction, future
  7 (4), p. 397-400 2003
• Journal of Interventional Cardiac Electrophysiology
  Diagnostic value of single versus dual chamber electrograms recorded from an implantable defibrillator
  9 (1), p. 49-53 2003
• Journal of the American College of Cardiology
  Maintenance of sinus rhythm in patients with atrial fibrillation:  an AFFIRM substudy of the first antiarrhythmic drug.
  42 (1), p. 20-29 2003
• American Heart Journal
  Use patterns of low molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation
  145 (4), p. 665-669 2003
• Annals of Emergency Medicine
  A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low molecular weight heparin
  40 (2), p. 187-192 2002
• Pacing and Clinical Electrophysiology
  The immediate reproducibility of T wave alternans during bicycle exercise
  25 (8), p. 1185-1191 2002
• American Journal of Cardiology
  Effect of amiodarone +/- diltiazem +/- beta-blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting
  89 (9), p. 1126-1128 2002
• International Journal of Cardiology
  Atrial fibrillation after coronary surgery:  comparison between different health care systems
  82 (3), p. 209-218 2002
• Journal of Cardiovascular Electrophysiology
  Kearns-Sayre Syndrome:  association with Long QT syndrome?
  13 (2), p. 184-185 2002
• Cardiology Review
  Importance of limiting atrial fibrillation after heart surgery
  19 (1), p. 19-23 2002
• American Journal of Cardiology
  Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter
  88 (12), p. 1428-1431 2001
• American Journal of Cardiology
  Clinical outcomes and costs associated with a first episode of uncomplicated atrial fibrillation presenting to the emergency room
  88 (1), p. 74-76 2001
• American Heart Journal
  Prevalence of central venous occlusion in patients with chronic defibrillator leads
  141 (5), p. 813-816 2001
• American Heart Journal
  Postoperative atrial fibrillation after heart surgery:  what are the goals of prevention?
  141 (5), p. 691-693 2001
• American Journal of Cardiology
  Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the postoperative atrial fibrillation in cardiac surgery study (PACS2)
  87 (7), p. 881-885 2001
• Journal of Cardiovascular Electrophysiology
  Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter
  12 (4), p. 393-399 2001
• International Journal of Cardiology
  Cardiac risk assessment in noncardiac thoracic surgery
  13 (2), p. 137-146 2001
• American Journal of Cardiology
  Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation
  87 (5), p. 649-651 2001
• Congestive Heart Failure
  Diastolic dysfunction in the presence of left ventricular systolic dysfunction: implications of beta-adrenergic blocking therapy
  7 (2), p. 71-76 2001
• Cardiovascular Reviews and Reports
  Pharmacologic and nonpharmacologic approaches to the prevention of atrial fibrillation after heart surgery
  22 (5), p. 292-296 2001
• Journal of Cardiovascular Pharmacology and Therapeutics
  Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment
  5 (4), p. 259-266 2000
• Circulation
  Effects of digoxin on acute, atrial fibrillaton-induced changes in atrial refractoriness
  102 (20), p. 2503-2508 2000
• Journal of the American College of Cardiology
  Diagnostic value of tachycardia features and pacing maneuvers during paroxsymal supraventricular tachycardia
  36 (2), p. 574-582 2000
• Journal of Cardiovascular Electrophysiology
  Effect of chronic amiodarone therapy on defibrillation energy requirements in humans
  11 (7), p. 736-740 2000
• Journal of Cardiovascular Electrophysiology
  Prevalence and significance of exit block during arrhythmias arising in pulmonary veins
  11 (4), p. 379-386 2000
• Journal of Cardiovascular Electrophysiology
  Comparison of endocardial activation times at effective and ineffective ablation sites within pulmonary veins
  11 (2), p. 155-159 2000
• American Journal of Cardiology
  Outcome of men with ischemic cardiomyopathy, asymptomatic nonsustained ventricular tachycardia, and negative electrophysiology studies
  85 (1), p. 119-121 2000
• American Journal of Cardiology
  Electrocardiographic predictors of successful ablation of tachycardia or bigeminy arising in the right ventricular outflow tract
  84 (10), p. 1266-1268 1999
• Circulation
  Bayesian persuasion
  100 (16), p. e68-e72 1999
• Circulation
  Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy
  100 (7), p. 729-735 1999
• American Journal of Cardiology
  Effect of electrode polarity on the energy required for transthoracic atrial defibrillation
  84 (2), p. 228-230 1999
• Journal of Cardiovascular Electrophysiology
  Target temperatures of 48 degrees celsius versus 60 degrees celsius during slow pathway ablation:  a randomized comparison
  10 (6), p. 799-803 1999
• Circulation
  Sudden death in a 55-year-old woman with systemic lupus erythematosus
  98 (3), p. 271-275 1998
• Clinical Cardiology
  Silent ischemic cardiomyopathy and left coronary ostial stenosis secondary to radiation therapy
  19 (7), p. 602 1996

Publications

• Circulation: Cardiovascular Quality and Outcomes
  Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation
  15.suppl_1, p. A68 2022
• J American College of Cardiology
  Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing
  79, Issue 9, Suppl A, p. 93 2022
• J American College of Cardiology
  Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study
  79, Issue 9, Suppl_1, p. 11-11 2022
• Circulation
  Outcomes of radiofrequency transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
  144, p. A14052 2021
• J American College of Cardiology
  Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 -2017)
  77, p. 231 2021
• Circulation
  Sex-related differences in health care utilization in patients with atrial flutter 2020
• Circulation: Cardiovascular Quality and Outcomes
  Population-level insights into 30-day mortality in medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation
  13 (Suppl_1), p. A341 2020
• J Am Coll Cardiol
  Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis
  75 (11), p. 420 2020
• J American College of Cardiology
  National economic cost burden of atrial flutter only patients without atrial fibrillation.
  73 (Supplement 1), p. 329 2019
• J Am Coll Cardiol
  Comparative variation in health care resource utilization between patients with atrial flutter only versus atrial fibrillation with or without atrial flutter.
  73 (Supplement 1), p. 332 2019

Presentations

• Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation. Poster at the Annual Scientific Sessions for Cardiovascular Quality and Outcomes Research 2022
• Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing. Poster presentation at the ACC Scientifc Sessions, Washington DC 2022
• Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study. Moderated Poster at ACC Scientifc Sessions, Washington DC. 2022
• Left ventricular lead placement using non-occlusive venogram for cardiac resynchronization therapy: a pilot study. Poster at 53rd Annual Midwest Student Biomedical Research Forum, Omaha, NE 2022
• Predictors of atrial fibrillation free survival in patients with implantable cardiac devices. Global Health Conference Midwest, Omaha, NE 2022
• Outcomes of Radiofrequency Transcatheter Ablation of Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis 2021
• Effect of post-procedural phone calls by Electrophysiology nurses on unplanned urgent care or emergency room visits after cardiac electrophysiology procedures. Poster at the ACC Annual Quality Summit 2021
• Andukuri V, Xu L, Puckrein G, Walters R, Kim MH. Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 - 2017). 2021: JACC 77 (18_Suppl 1_), 231. Presented at American College of Cardiology Annual Scientific Sessions. 2021
• Kim K, Kim S, Kim MH. Sex-related differences in health care utilization in patients with atrial flutter. Circulation 2020; 142 (Suppl_3), A12593. Presented at Annual Scientific Session of the American Heart Association. 2020
• Andukuri V, Xu L, Puckrein GA, Walters RW, Kim MH.  Population-level insights into 30-day mortality in Medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation.  Virtual Abstract Poster Session at AHA Quality of Care and Outcomes Scientific Sessions. 2020
• American College of Cardiology Scientific Sessions Poster Presentation (Virtual): Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis 2020
• Internal Medicine Grand Rounds:  Do We Really Know Atrial Flutter: Clinical and Epidemiological Perspectives 2020
• American College of Cardiology Scientific Sessions Abstract Presentation (Poster): National Economic Cost Burden of Atrial Flutter Only Patients Without Atrial Fibrillation; New Orleans, LA 2019
• American College of Cardiology Scientific Sessions Abstract Presentation (Poster): Comparative Variation in Health Care Resource Utilization Between Patients With Atrial Flutter Only Versus Atrial Fibrillation With Or Without Atrial Flutter; New Orleans, LA 2019
• Invited Lecture:  Cardiovascular Outcomes and Atrial Fibrillation; Maricopa Medical Center; Phoenix, AZ 2019

Awards

• Remarkable Reviewer Award 2021
  For work on the Heart Rhythm Journal in 2020
  Heart Rhythm Society
• Remarkable Reviewer Award 2018
  Heart Rhythm Journal
• Remarkable Reviewer Award 2017
  For work in 2016
  Heart Rhythm Journal
• Elite/Top Reviewer Award: 2014, 2015, and 2016
  Awarded only to 10 or less Journal Reviewers
  Journal of the American College of Cardiology
• Top Grade/Best Reviewers Designation, 2012
  Annals of Internal Medicine
• NASPE Traveling Fellowship
  North American Society of Pacing and Electrophysiology
• Midwest Trainee Investigator Award
  Central Society for Clinical Research